These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3007264)

  • 41. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E
    Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome.
    Haab F; Cardozo L; Chapple C; Ridder AM;
    Eur Urol; 2005 Mar; 47(3):376-84. PubMed ID: 15716204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cardio-circulatory effects of a new beta-adrenergic agent: clenbuterol].
    Pasotti C; Gandolfi P
    Boll Soc Ital Cardiol; 1981; 26(9):873-5. PubMed ID: 7347270
    [No Abstract]   [Full Text] [Related]  

  • 44. [Oral tocolytic therapy with clenbuterol--clinical facts].
    Meinen K; Rahn M; Hermer M; Rominger KL; Kanitz T
    Z Geburtshilfe Perinatol; 1988; 192(4):163-8. PubMed ID: 3188600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of dietary clenbuterol and cimaterol on muscle composition, beta-adrenergic and androgen receptor concentrations in broiler chickens.
    Schiavone A; Tarantola M; Perona G; Pagliasso S; Badino P; Odore R; Cuniberti B; Lussiana C
    J Anim Physiol Anim Nutr (Berl); 2004 Apr; 88(3-4):94-100. PubMed ID: 15059232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cizolirtine citrate, an effective treatment for symptomatic patients with urinary incontinence secondary to overactive bladder: a pilot dose-finding study.
    Martínez-García R; Abadías M; Arañó P; Perales L; Ruíz JL; Sust M; Conejero J;
    Eur Urol; 2009 Jul; 56(1):184-90. PubMed ID: 18485575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Bronchodilator and bronchial hyperreactivity-inhibiting effects of clenbuterol in patients with bronchial asthma].
    Chazan R; Kokot M; Droszcz W
    Pneumonol Pol; 1986 Oct; 54(10):437-42. PubMed ID: 2883628
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of vaginal estrogen therapy on urinary incontinence in postmenopause].
    Schär G; Köchli OR; Fritz M; Haller U
    Zentralbl Gynakol; 1995; 117(2):77-80. PubMed ID: 7709677
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Study of a new oral beta-adrenergic drug, clenbuterol, in patients with chronic bronchitis.
    Baronti A; Griceo A; Vibelli C
    Eur J Clin Pharmacol; 1978 May; 13(3):171-7. PubMed ID: 352703
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of clenbuterol in asthma induced by exercise in children].
    Salvadó A; Yáñez M; Robles B
    Rev Chil Pediatr; 1985; 56(1):38-41. PubMed ID: 4081177
    [No Abstract]   [Full Text] [Related]  

  • 51. Clenbuterol ("Spiropent'): a long-acting bronchodilator.
    Wheatley D
    Curr Med Res Opin; 1982; 8(2):113-9. PubMed ID: 7049586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of clenbuterol on lung function parameters in calves suffering from bronchopneumonia.
    Nuytten J; Muylle E; Oyaert W; Van den Hende C
    Vet Res Commun; 1986 Nov; 10(6):463-7. PubMed ID: 3798736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spiropent (clenbuterol): another choice for patients with chronic reversible airways obstruction.
    Su WJ; Perng RP
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jan; 47(1):13-7. PubMed ID: 1848457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clenbuterol in amyotrophic lateral sclerosis. No indication for a positive effect].
    Puls I; Beck M; Giess R; Magnus T; Ochs G; Toyka KV
    Nervenarzt; 1999 Dec; 70(12):1112-5. PubMed ID: 10637819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clenbuterol not approved for use in cattle in Canada.
    Drennan WG; Yong MS
    Can Vet J; 1994 Aug; 35(8):474-5. PubMed ID: 7954218
    [No Abstract]   [Full Text] [Related]  

  • 56. A tendency to pay more attention to what something is called rather than what it is.
    Chamberlain J
    J Pharm Pharmacol; 1993 Sep; 45(9):769. PubMed ID: 7903361
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of urinary urgency symptoms in the female with the beta-2-sympathomimetic clenbuterol].
    Voigt R; Martan A; Halaska M; Sindlar M; Voigt P
    Geburtshilfe Frauenheilkd; 1986 Feb; 46(2):115-7. PubMed ID: 3007264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of motor urge incontinence with the beta 2-sympathomimetic drug clenbuterol (author's transl)].
    Grüneberger A; Geier G
    Urologe A; 1981 May; 20(3):153-4. PubMed ID: 6115496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical effects of clenbuterol-HCL in urge incontinence and stress incontinence].
    Yamanishi T; Yasuda K; Nagashima K; Naoto ; Murayama ; Tojo M; Shimazaki J
    Hinyokika Kiyo; 1990 Feb; 36(2):207-11. PubMed ID: 2343815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of urgency incontinence using the beta-mimetic, clenbuterol].
    Martan A; Sindlár M; Halaska M; Koleska T; Stulc B
    Cesk Gynekol; 1986 Aug; 51(7):535-9. PubMed ID: 3757080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.